Ascendis Pharma (ASND)
(Delayed Data from NSDQ)
$151.26 USD
-2.17 (-1.41%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $151.34 +0.08 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-1.51 | 4.60% |
Earnings Summary
For their last quarter, Ascendis Pharma (ASND) reported earnings of -$2.05 per share, missing the Zacks Consensus Estimate of -$1.54 per share. This reflects a negative earnings surprise of 33.12%. Look out for ASND's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$1.51 per share, reflecting a year-over-year increase of 51.6%.
Earnings History
Price & Consensus
Zacks News for ASND
Ascendis Pharma (ASND) Moves 17.1% Higher: Will This Strength Last?
ASND: What are Zacks experts saying now?
Zacks Private Portfolio Services